Methotrexate hydrate, powder, BioReagent, suitable for cell culture, >=98% (HPLC)

Methotrexate hydrate, powder, BioReagent, suitable for cell culture, >=98% (HPLC)

Application

Potent inhibitor of dihydrofolate reductase and agent for antitumor studies. Use to inhibit dihydrofolate reductase in DHFR-based protein expression systems. Also shows immunosuppressive effects in, e.g., rheumatoid arthritis.

Methotrexate hydrate has been used: as a dihydrofolate (DHFR)inhibitor in sphere forming assay cultureas a component of dulbecco? modified Eagle?s medium (DMEM) for selection of transfected cells in viability and co-culture assays

Potent inhibitor of dihydrofolate reductase and agent for antitumor studies. Use to inhibit dihydrofolate reductase in DHFR-based protein expression systems. Also effective in treatment of pyrimethamine-resistant Plasmodium vivax malaria parasites.

Biochem/physiol Actions

Methotrexate used to inhibit dihyrofolate reductase and select for DHFR overexpresssion.

Methotrexate is a folic acid antagonist.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Pack InChI key InChI Manufacturer Product Line Form Assay Price Quantity
3571983 Methotrexate hydrate, powder, BioReagent, suitable for cell culture, >=98% (HPLC) 100MG FPJYMUQSRFJSEW-ZOWNYOTGSA-N 1S/C20H22N8O5.H2O/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30 SIGMA-ALDRICH
£370.00 (exc VAT) per 100MG
-
+
3571984 Methotrexate hydrate, powder, BioReagent, suitable for cell culture, >=98% (HPLC) 500MG FPJYMUQSRFJSEW-ZOWNYOTGSA-N 1S/C20H22N8O5.H2O/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30 SIGMA-ALDRICH
Click Add to Quote for price and delivery
-
+